Archived Seminar: Neurovascular Interactions: Mechanisms, Imaging, Therapeutics
Pioneers in Biomedical Research Seminar presented by the Fralin Biomedical Research Institute at VTC
About This Seminar
The communication between the brain, immune and vascular systems is a key contributor to the onset and progression of neurological diseases. Dr. Akassoglou’s research has uncovered the blood clotting factor fibrinogen as a driver of neuroinflammation, as common thread in a wide range of neurologic diseases, such as multiple sclerosis, Alzheimer’s disease and neurodegenerative diseases. Her lab developed cutting-edge imaging tools to study the neurovascular interface and discovered a role for fibrin in microglia-mediated oxidative stress-dependent spine elimination and novel fibrin-targeting immunotherapy to protect the brain from pathogenic neuroinflammation. Recent advances in functional single-cell transcriptional profiling of neurotoxic innate immunity (Tox-Seq) allowed the development of the oxidative stress cell atlas at the neurovascular interface. These findings could be a common thread for the understanding of the etiology, mechanisms of progression, and the development of new treatments for neurologic diseases with neuroimmune and cerebrovascular dysfunction.
This is a free event hosted by the Fralin Biomedical Research Institute and co-sponsored by the institute's Center for Neurobiology Research and the Center for Glial Biology in Health, Disease, and Cancer. The Fralin Biomedical Research Institute Pioneers in Biomedical Research Program offers the expertise of a range of scientists who are exploring frontiers in biomedical research. These seminars are open to Virginia Tech and Carilion Clinic faculty, students, and staff.
You May Also Be Interested In...
General ItemVirtual Public Lecture: How Vaccines Train the Immune System in Ways No One Expected
April 15, 2021, 5:30 p.m. | Christine Stabell Benn, M.D., Ph.D., D.M.Sc. | Maury Strauss Distinguished Public Lecture
General ItemVirtual Seminar: Aerobic Fitness and Susceptibility for Metabolic Dysfunction
April 16, 2021, 11 a.m. | John Thyfault, Ph.D. | Pioneers in Biomedical Research Seminar Series
General ItemVirtual Lecture: Mechanism of Treatment Resistance in Human Glioblastoma
April 16, 2021, 1 p.m. | W.K. Alfred Yung, M.D. | Timothy A. Johnson Medical Scholar Seminar Series
General ItemVirtual Seminar: Multi-channel MEG Measurements with a Wearable OPM System
April 23, 2021, 11 a.m. | Elena Boto, Ph.D. | Pioneers in Biomedical Research Seminar Series
General ItemVirtual Seminar: Control of TGF-beta Signaling and Epithelial-Mesenchymal Transition
April 30, 2021, 11 a.m. | Rik Derynck, Ph.D. | Pioneers in Biomedical Research Seminar Series
Katerina Akassoglou, Ph.D.
Senior Investigator at the Gladstone Institutes; and a Professor in the Department of Neurology at the University of California San Francisco